MODULATION OF THE HUMAN INTERLEUKIN-6 PROMOTER (IL-6) AND TRANSCRIPTION FACTOR-C EBP BETA (NF-IL6) ACTIVITY BY P53 SPECIES/

Citation
L. Margulies et Pb. Sehgal, MODULATION OF THE HUMAN INTERLEUKIN-6 PROMOTER (IL-6) AND TRANSCRIPTION FACTOR-C EBP BETA (NF-IL6) ACTIVITY BY P53 SPECIES/, The Journal of biological chemistry, 268(20), 1993, pp. 5096-5100
Citations number
55
Categorie Soggetti
Biology
ISSN journal
00219258
Volume
268
Issue
20
Year of publication
1993
Pages
5096 - 5100
Database
ISI
SICI code
0021-9258(1993)268:20<5096:MOTHIP>2.0.ZU;2-Y
Abstract
Constitutive up-regulation of interleukin-6 (IL-6) gene expression is observed in many neoplastic cell lines. The contribution of mutations in p53 to the up-regulation of the IL-6 promoter was evaluated in tran sient transfection experiments. In HeLa cells, wild-type (wt) human or murine p53 preferentially repressed the IL-6 promoter. The p53 mutant s Val-135 and Phe-132 up-regulated IL-6 promoter activity in these cel ls at both 32.5 and 37-degrees-C. The temperature-sensitive Val-135 mu tant was not only not inhibitory or ''wt-like'' at the lower temperatu re, but had gained a transcriptional activator phenotype which was tem perature-independent in HeLa cells. The functional DNA target for tran scriptional modulation of the IL-6 promoter by p53 species included th e multiple cytokine- and second messenger-response element (-173 to -1 45); point mutations in the transcription factor C/EBPbeta-binding sit e within the second messenger-response element largely blocked the abi lity of p53 mutants Val-135 and Phe-132 to up-regulate this promoter. The up-regulation of IL-6 promoter constructs by co-transfection into HeLa cells of a C/EBPbeta constitutive expression vector was blocked i n a dominant negative manner by wt p53. In contrast, the p53 mutants V al-135 and Phe-132 further enhanced C/EBPbeta-mediated up-regulation o f IL-6 promoter constructs. The modulation of C/EBPbeta function by p5 3 species provides a basis for the involvement of p53 not only in the regulation of cytokine synthesis but also in the altered responsivenes s of tumor cells to cytokines.